ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen " Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West "
Episode Synopsis
Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West
In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements.
If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%.
MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe to the DeviceTalks Podcast Network.
More episodes of the podcast DeviceTalks Podcast Network
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs
14/11/2025
Reimagining GI with AI: Olympus’ Blended Intelligence Approach to Burnout Relief & Patient Safety
11/11/2025
Medtronic’s Kowal describes an exciting future and new applications for cardiac pacing devices
07/11/2025
How Abbott is rethinking heart failure management through smarter monitoring and long-term support
27/10/2025
In God we trust